TREA

98018569 - CELEMICS

Follow

Information

  • Trademark
  • 98018569
  • Serial Number
    98018569
  • Registration Number
    7845163
  • Filing Date
    May 30, 2023
    2 years ago
  • Registration Date
    June 24, 2025
    9 months ago
  • Transaction Date
    June 24, 2025
    9 months ago
  • Status Date
    June 24, 2025
    9 months ago
  • Published for Opposition Date
    July 30, 2024
    a year ago
  • Location Date
    June 04, 2025
    9 months ago
  • First Use Anywhere Date
    February 20, 2025
    a year ago
  • First Use In Commerce Date
    February 20, 2025
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LIU, PHILIP
  • Attorney Docket Number
    TUS230038
    Attorney Name
    minchul yang
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
3
Mark Identification
CELEMICS
Case File Statements
  • DM0000: The mark consists of the word "CELEMICS" with a helix to the left of the word.
  • GS0051: Biotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; chemical preparations for use in DNA analysis for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; in vitro diagnostic preparations for medical purposes; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Research and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; chemical research; research for medical products, namely, medical research; scientific research in the nature of conducting clinical trials for others in the field of oncology, cardiovascular disease, neurology, immunology, and genomics; biotechnology research; biochemical research; providing information of scientific research.
Case File Event Statements
  • 6/2/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/29/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/30/2023 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/22/2024 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/1/2024 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/1/2024 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/1/2024 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/27/2024 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/27/2024 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/12/2024 - a year ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/12/2024 - a year ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/12/2024 - a year ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/12/2024 - a year ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/12/2024 - a year ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/27/2024 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/10/2024 - a year ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/30/2024 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/24/2024 - a year ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/10/2025 - a year ago
    20 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 6/3/2025 - 9 months ago
    21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/30/2024 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/9/2025 - a year ago
    22 - USE AMENDMENT FILED Type: IUAF
  • 6/2/2025 - 9 months ago
    23 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 6/4/2025 - 9 months ago
    24 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 6/4/2025 - 9 months ago
    25 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/24/2025 - 9 months ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/24/2025 - 9 months ago
    27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC